Global Diabetic Lancet Device Market Research Report 2024

Publication ID:

PB508241616

Publication Date:

August 19, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A diabetes blood sampling device is a medical instrument used by diabetic patients for blood glucose monitoring.
The global Diabetic Lancet Device market was valued at US$ 302 million in 2023 and is anticipated to reach US$ 384.8 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
A diabetes blood sampling device is an essential medical tool for individuals living with diabetes. This device comprises several key components, including a lancet, a glucose meter, test strips, a lancet device, and a logbook. The lancet is a fine needle used to puncture the skin, allowing for the collection of a small blood sample. This sample is then placed on a test strip, which contains specialized chemicals for glucose detection. The test strip is inserted into a glucose meter, an electronic device that measures the blood glucose level and displays the result in numerical form. To ensure a relatively painless and effective blood sampling process, the lancet device's depth can be adjusted. Patients often use a logbook to record their blood glucose levels, diet, physical activity, and medication intake, providing a comprehensive picture of their diabetes management. Regular blood glucose monitoring with these devices is crucial for maintaining blood sugar levels within the target range and facilitating effective diabetes management. With ongoing advancements, more intelligent and user-friendly blood glucose monitoring solutions continue to emerge, enhancing the convenience and accuracy of diabetes care.
This report aims to provide a comprehensive presentation of the global market for Diabetic Lancet Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Lancet Device.
Report Scope
The Diabetic Lancet Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Lancet Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Lancet Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
BIONIME
Yuwell
Segment by Type
50 Test Strips
100 Test Strips
150 Test Strips
200 Test Strips
Segment by Application
Hospitals and Clinics
Household Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetic Lancet Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetic Lancet Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Diabetic Lancet Device Market Overview
1.1 Product Overview and Scope of Diabetic Lancet Device
1.2 Diabetic Lancet Device Segment by Type
1.2.1 Global Diabetic Lancet Device Market Value Comparison by Type (2024-2030)
1.2.2 50 Test Strips
1.2.3 100 Test Strips
1.2.4 150 Test Strips
1.2.5 200 Test Strips
1.3 Diabetic Lancet Device Segment by Application
1.3.1 Global Diabetic Lancet Device Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Household Use
1.4 Global Diabetic Lancet Device Market Size Estimates and Forecasts
1.4.1 Global Diabetic Lancet Device Revenue 2019-2030
1.4.2 Global Diabetic Lancet Device Sales 2019-2030
1.4.3 Global Diabetic Lancet Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diabetic Lancet Device Market Competition by Manufacturers
2.1 Global Diabetic Lancet Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diabetic Lancet Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diabetic Lancet Device Average Price by Manufacturers (2019-2024)
2.4 Global Diabetic Lancet Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetic Lancet Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Lancet Device, Product Type & Application
2.7 Diabetic Lancet Device Market Competitive Situation and Trends
2.7.1 Diabetic Lancet Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetic Lancet Device Players Market Share by Revenue
2.7.3 Global Diabetic Lancet Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetic Lancet Device Retrospective Market Scenario by Region
3.1 Global Diabetic Lancet Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diabetic Lancet Device Global Diabetic Lancet Device Sales by Region: 2019-2030
3.2.1 Global Diabetic Lancet Device Sales by Region: 2019-2024
3.2.2 Global Diabetic Lancet Device Sales by Region: 2025-2030
3.3 Global Diabetic Lancet Device Global Diabetic Lancet Device Revenue by Region: 2019-2030
3.3.1 Global Diabetic Lancet Device Revenue by Region: 2019-2024
3.3.2 Global Diabetic Lancet Device Revenue by Region: 2025-2030
3.4 North America Diabetic Lancet Device Market Facts & Figures by Country
3.4.1 North America Diabetic Lancet Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diabetic Lancet Device Sales by Country (2019-2030)
3.4.3 North America Diabetic Lancet Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diabetic Lancet Device Market Facts & Figures by Country
3.5.1 Europe Diabetic Lancet Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diabetic Lancet Device Sales by Country (2019-2030)
3.5.3 Europe Diabetic Lancet Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Lancet Device Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetic Lancet Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diabetic Lancet Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Diabetic Lancet Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diabetic Lancet Device Market Facts & Figures by Country
3.7.1 Latin America Diabetic Lancet Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diabetic Lancet Device Sales by Country (2019-2030)
3.7.3 Latin America Diabetic Lancet Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Lancet Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Lancet Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diabetic Lancet Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diabetic Lancet Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetic Lancet Device Sales by Type (2019-2030)
4.1.1 Global Diabetic Lancet Device Sales by Type (2019-2024)
4.1.2 Global Diabetic Lancet Device Sales by Type (2025-2030)
4.1.3 Global Diabetic Lancet Device Sales Market Share by Type (2019-2030)
4.2 Global Diabetic Lancet Device Revenue by Type (2019-2030)
4.2.1 Global Diabetic Lancet Device Revenue by Type (2019-2024)
4.2.2 Global Diabetic Lancet Device Revenue by Type (2025-2030)
4.2.3 Global Diabetic Lancet Device Revenue Market Share by Type (2019-2030)
4.3 Global Diabetic Lancet Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diabetic Lancet Device Sales by Application (2019-2030)
5.1.1 Global Diabetic Lancet Device Sales by Application (2019-2024)
5.1.2 Global Diabetic Lancet Device Sales by Application (2025-2030)
5.1.3 Global Diabetic Lancet Device Sales Market Share by Application (2019-2030)
5.2 Global Diabetic Lancet Device Revenue by Application (2019-2030)
5.2.1 Global Diabetic Lancet Device Revenue by Application (2019-2024)
5.2.2 Global Diabetic Lancet Device Revenue by Application (2025-2030)
5.2.3 Global Diabetic Lancet Device Revenue Market Share by Application (2019-2030)
5.3 Global Diabetic Lancet Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Diabetic Lancet Device Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Corporation Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lifescan Diabetic Lancet Device Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Diabetic Lancet Device Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ascensia Diabetic Lancet Device Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Diabetic Lancet Device Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 TERUMO
6.6.1 TERUMO Corporation Information
6.6.2 TERUMO Description and Business Overview
6.6.3 TERUMO Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TERUMO Diabetic Lancet Device Product Portfolio
6.6.5 TERUMO Recent Developments/Updates
6.7 Sinocare
6.6.1 Sinocare Corporation Information
6.6.2 Sinocare Description and Business Overview
6.6.3 Sinocare Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinocare Diabetic Lancet Device Product Portfolio
6.7.5 Sinocare Recent Developments/Updates
6.8 ARKRAY
6.8.1 ARKRAY Corporation Information
6.8.2 ARKRAY Description and Business Overview
6.8.3 ARKRAY Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ARKRAY Diabetic Lancet Device Product Portfolio
6.8.5 ARKRAY Recent Developments/Updates
6.9 BIONIME
6.9.1 BIONIME Corporation Information
6.9.2 BIONIME Description and Business Overview
6.9.3 BIONIME Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BIONIME Diabetic Lancet Device Product Portfolio
6.9.5 BIONIME Recent Developments/Updates
6.10 Yuwell
6.10.1 Yuwell Corporation Information
6.10.2 Yuwell Description and Business Overview
6.10.3 Yuwell Diabetic Lancet Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yuwell Diabetic Lancet Device Product Portfolio
6.10.5 Yuwell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Lancet Device Industry Chain Analysis
7.2 Diabetic Lancet Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Lancet Device Production Mode & Process
7.4 Diabetic Lancet Device Sales and Marketing
7.4.1 Diabetic Lancet Device Sales Channels
7.4.2 Diabetic Lancet Device Distributors
7.5 Diabetic Lancet Device Customers
8 Diabetic Lancet Device Market Dynamics
8.1 Diabetic Lancet Device Industry Trends
8.2 Diabetic Lancet Device Market Drivers
8.3 Diabetic Lancet Device Market Challenges
8.4 Diabetic Lancet Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
BIONIME
Yuwell

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂